We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.5%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$570M
(+3.3%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
20.72%
Holding
1,372
New
93
Increased
502
Reduced
569
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$54.9M |
| 2 |
Accenture
ACN
|
+$54.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$36.3M |
| 4 |
Gartner
IT
|
+$35.8M |
| 5 |
Humana
HUM
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$61.7M |
| 2 |
Danaher
DHR
|
+$38.4M |
| 3 |
Progressive
PGR
|
+$36.4M |
| 4 |
Automatic Data Processing
ADP
|
+$33.9M |
| 5 |
Paychex
PAYX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.97% |
| 2 | Healthcare | 12.8% |
| 3 | Financials | 9.66% |
| 4 | Consumer Discretionary | 8.95% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11B
| $259K | ﹤0.01% |
2,371
+225
| +10% | +$24.4K |
|
1027
Axsome Therapeutics
AXSM
$11.7B
| $257K | ﹤0.01% |
4,172
-2,390
| -36% | -$157K |
|
1028
HEICO Corp Class A
HEI.A
$36B
| $257K | ﹤0.01% |
1,892
-102
| -5% | -$13.5K |
|
1029
Kirby Corp
KEX
$7.01B
| $257K | ﹤0.01% |
3,683
+508
| +16% | +$35K |
|
1030
Booz Allen Hamilton
BAH
$8.44B
| $255K | ﹤0.01% |
2,750
-285,302
| -99% | -$27.1M |
|
1031
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$382M
| $255K | ﹤0.01% |
2,686
| – | – |
|
1032
Arrowhead Research
ARWR
$12.1B
| $255K | ﹤0.01% |
10,029
-5,634
| -36% | -$177K |
|
1033
AXIS Capital
AXS
$7.81B
| $253K | ﹤0.01% |
4,634
+479
| +12% | +$27.8K |
|
1034
VanEck Agribusiness ETF
MOO
$992M
| $252K | ﹤0.01% |
2,903
+101
| +4% | +$8.92K |
|
1035
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $252K | ﹤0.01% |
5,520
-92
| -2% | -$4.18K |
|
1036
VF Corp
VFC
$5.92B
| $252K | ﹤0.01% |
10,984
-3,713
| -25% | -$97.6K |
|
1037
ATI
ATI
$24.3B
| $251K | ﹤0.01% |
+6,369
| New | +$240K |
|
1038
Wheaton Precious Metals
WPM
$49.7B
| $251K | ﹤0.01% |
+5,202
| New | +$227K |
|
1039
iShares Europe ETF
IEV
$1.64B
| $250K | ﹤0.01% |
5,000
| – | – |
|
1040
iShares MSCI USA Value Factor ETF
VLUE
$9.03B
| $250K | ﹤0.01% |
2,695
-605
| -18% | -$56.9K |
|
1041
Hillman Solutions
HLMN
$1.57B
| $249K | ﹤0.01% |
29,610
-1,155
| -4% | -$10K |
|
1042
Liberty Media Series C
FWONK
$25.5B
| $249K | ﹤0.01% |
3,438
-51
| -1% | -$3.45K |
|
1043
Houlihan Lokey
HLI
$9.72B
| $249K | ﹤0.01% |
2,843
+54
| +2% | +$5.08K |
|
1044
Huntsman Corp
HUN
$2.1B
| $248K | ﹤0.01% |
+9,079
| New | +$271K |
|
1045
Madrigal Pharmaceuticals
MDGL
$12.6B
| $248K | ﹤0.01% |
+1,023
| New | +$279K |
|
1046
Enovis
ENOV
$1.74B
| $247K | ﹤0.01% |
4,627
+171
| +4% | +$9.91K |
|
1047
Prothena Corp
PRTA
$448M
| $246K | ﹤0.01% |
5,069
-323
| -6% | -$17.1K |
|
1048
Jones Lang LaSalle
JLL
$15.8B
| $245K | ﹤0.01% |
1,685
-4,443
| -73% | -$741K |
|
1049
PG&E
PCG
$39B
| $245K | ﹤0.01% |
15,147
+828
| +6% | +$13.1K |
|
1050
Scotiabank
BNS
$105B
| $244K | ﹤0.01% |
4,845
-3,012
| -38% | -$155K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q1 2023 Portfolio in Review
As of Q1 2023, Glenmede Trust held 1,372 positions worth $17.6B, up 3.3% from $17B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Glenmede Trust's Q1 2023 filing shows 93 new, 502 increased, 569 reduced and 82 closed positions. Its largest new stake was Zoom: 177,014 shares worth $13.1M. The largest sale was Advanced Micro Devices, an estimated $61.7M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q1 2023 buy was Zoom: 177,014 shares worth $13.1M.
- Glenmede Trust added most to Procter & Gamble in Q1 2023, an estimated $54.9M increase.
- Glenmede Trust's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $61.7M.
- Glenmede Trust fully exited Matador Resources in Q1 2023, selling an estimated $17.9M.
- Glenmede Trust's ten largest holdings make up 21% of its $17.6B portfolio in Q1 2023.
- Glenmede Trust opened 93 new positions and closed 82 in Q1 2023.
- Glenmede Trust's portfolio value rose 3.3% quarter-over-quarter to $17.6B.
Based on Glenmede Trust's 13F filing for Q1 2023, filed 15 May 2023.